Recent Advances in the Development of Non‐Invasive Imaging Probes for Cancer Immunotherapy
Angewandte Chemie International Edition · 08.01.2024 · 63 (2)
DOI: 10.1002/anie.202310694 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 26.10.2023. Verfasst von Muhammad Kazim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 173 Literaturangaben. Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
The last two decades have witnessed a major revolution in the field of tumor immunology including clinical progress using various immunotherapy strategies. These advances have highlighted the potential for approaches that harness the power of the immune system to fight against cancer. While cancer immunotherapies have shown significant clinical successes, patient responses vary widely due to the complex and heterogeneous nature of tumors and immune responses, calling for reliable biomarkers and therapeutic strategies to maximize the benefits of immunotherapy. Especially, stratifying responding individuals from non‐responders during the early stages of treatment could help avoid long‐term damage and tailor personalized treatments. In efforts to develop non‐invasive means for accurately evaluating and predicting tumor response to immunotherapy, multiple affinity‐based agents targeting immune cell markers and checkpoint molecules have been developed and advanced to clinical trials. In addition, researchers have recently turned their attention to substrate and activity‐based imaging probes that can provide real‐time, functional assessment of immune response to treatment. Here, we highlight some of those recently designed probes that image functional proteases as biomarkers of cancer immunotherapy with a focus on their chemical design and detection modalities and discuss challenges and opportunities for the development of imaging tools utilized in cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Biology Laboratory, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.
ORCID-Profile: Muhammad Kazim, Euna Yoo
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Kazim, M., & Yoo, E. (2024). Recent Advances in the Development of Non‐Invasive Imaging Probes for Cancer Immunotherapy. Angewandte Chemie International Edition, 63(2). https://doi.org/10.1002/anie.202310694
Vancouver
Kazim M, Yoo E. Recent Advances in the Development of Non‐Invasive Imaging Probes for Cancer Immunotherapy. Angewandte Chemie International Edition. 2024;63(2). doi:10.1002/anie.202310694
BibTeX
@article{Kazim2024,
author = {Kazim, Muhammad and Yoo, Euna},
title = {Recent Advances in the Development of Non‐Invasive Imaging Probes for Cancer Immunotherapy},
journal = {Angewandte Chemie International Edition},
year = {2024},
volume = {63},
number = {2},
doi = {10.1002/anie.202310694}
}
EUVIMED